EUVIMEDEUVIMED entdecken
BeobachtungsstudieStudienprotokollOpen Access · CC BY 4.0

Clinical, immune and genetic risk factors of malaria-associated acute kidney injury in Zambian children: A study protocol

Chisambo Mwaba iD, Sody Munsaka iD, David Mwakazanga iD, David Rutagwerae, Owen Ngalamika, Suzanna Mwanza iD, Mignon McCulloch, Evans Mpabalwani iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0316205 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS ONE, 2025. Verfasst von Chisambo Mwaba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Child Health, School of Medicine, University of Zambia, Lusaka, Zambia. Hauptthemen laut MEDLINE: Acute Kidney Injury, Malaria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute kidney injury (AKI) affects nearly half of children with severe malaria and increases the risk of adverse outcomes such as death and poor cognitive function. The pathogenesis and predictors of malaria-associated acute kidney injury (MAKI) are not fully described. This study aims to determine the clinical, immune, and genetic correlates of risk to AKI in Zambian children admitted with malaria. In addition, we intend to assess a modified renal angina index (mRAI), kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and soluble urokinase receptor (suPAR), when done on the first day of admission, for the ability to predict AKI two days later (day 3) in children admitted with malaria.

Methods

This is an unmatched case-control study with a nested prospective observational study. A case-to-control ratio of 1:1 is used and 380 children with malaria and aged less than 16 years are being recruited from two hospitals in Zambia. Eligible children are recruited after obtaining written informed consent. Recruitment occurs during the malaria season and began on 6 th March 2024 and will continue until July 2025. AKI is defined using the 2012 KIDGO AKI creatinine criteria, and cases are defined as children admitted with malaria who develop AKI within 72 hours of admission, while controls are children admitted with malaria but with no AKI. Serum creatinine is collected on Day 1 within 24 hours of admission, on Day 3 and then again on discharge or day 7, whichever comes sooner. Baseline biomarker concentrations will be determined using the Luminex multiplex Elisa system or high-sensitivity ELISA. SPSS version 29 will be used for data analysis. Descriptive statistics and inferential statistical tests will be run as appropriate. A p ≤ 0.05 will be considered as significant. The sensitivity, specificity, and estimates of the area under the curve (AUC) for the renal angina score will be determined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryMalariaHumansZambiaCase-Control StudiesChild, PreschoolChildRisk FactorsMaleFemaleProspective StudiesInfantBiomarkersLipocalin-2Hepatitis A Virus Cellular Receptor 1AdolescentReceptors, Urokinase Plasminogen Activator

Substanzen

BiomarkersLipocalin-2Hepatitis A Virus Cellular Receptor 1HAVCR1 protein, humanReceptors, Urokinase Plasminogen Activator

Autor:innen und Institutionen

  • Department of Paediatrics and Child Health, School of Medicine, University of Zambia, Lusaka, Zambia.
  • Department of Paediatrics, University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • Department of Biomedical Sciences, School of Health Sciences, University of Zambia, Lusaka, Zambia.
  • Public Health Department, Epidemiology and Statistics Unit, Tropical Diseases Research Centre, Ndola, Zambia.
  • Kaposi's Sarcoma Molecular Laboratory, Paediatric Centre of Excellence, University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • Dermatology and Venereology Division, Department of Internal Medicine, University Teaching Hospital, University of Zambia School of Medicine, Lusaka, Zambia.

ORCID-Profile: Chisambo Mwaba, Sody Munsaka, David Mwakazanga, Suzanna Mwanza, Evans Mpabalwani

Förderung

  • Ministry of Science and Technology

Zitieren

APA

Mwaba, C., Munsaka, S., Mwakazanga, D., Rutagwerae, D., Ngalamika, O., Mwanza, S., McCulloch, M., & Mpabalwani, E. (2025). Clinical, immune and genetic risk factors of malaria-associated acute kidney injury in Zambian children: A study protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0316205

Vancouver

Mwaba C, Munsaka S, Mwakazanga D, Rutagwerae D, Ngalamika O, Mwanza S, et al. Clinical, immune and genetic risk factors of malaria-associated acute kidney injury in Zambian children: A study protocol. PLOS ONE. 2025. doi:10.1371/journal.pone.0316205

BibTeX
@article{Mwaba2025,
  author = {Mwaba, Chisambo and Munsaka, Sody and Mwakazanga, David and Rutagwerae, David and Ngalamika, Owen and Mwanza, Suzanna and McCulloch, Mignon and Mpabalwani, Evans},
  title = {Clinical, immune and genetic risk factors of malaria-associated acute kidney injury in Zambian children: A study protocol},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0316205}
}
Kostenlos starten →